| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-09 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.19 | 1e-08 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-08 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.18 | 2e-08 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-08 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-08 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-08 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.18 | 4e-08 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-08 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.21 | 4e-08 |